DK0409040T3 - Kolonistimulerende faktoraktivitetspromotorer - Google Patents

Kolonistimulerende faktoraktivitetspromotorer

Info

Publication number
DK0409040T3
DK0409040T3 DK90113097.1T DK90113097T DK0409040T3 DK 0409040 T3 DK0409040 T3 DK 0409040T3 DK 90113097 T DK90113097 T DK 90113097T DK 0409040 T3 DK0409040 T3 DK 0409040T3
Authority
DK
Denmark
Prior art keywords
stimulating factor
factor activity
colony
mip
myelopoietic
Prior art date
Application number
DK90113097.1T
Other languages
Danish (da)
English (en)
Inventor
Stephen D Wolpe
Anthony Cerami
Barbara Sherry
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of DK0409040T3 publication Critical patent/DK0409040T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/195Chemokines, e.g. RANTES
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/21Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/22Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
DK90113097.1T 1989-07-10 1990-07-09 Kolonistimulerende faktoraktivitetspromotorer DK0409040T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37793789A 1989-07-10 1989-07-10

Publications (1)

Publication Number Publication Date
DK0409040T3 true DK0409040T3 (da) 1995-12-27

Family

ID=23491090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90113097.1T DK0409040T3 (da) 1989-07-10 1990-07-09 Kolonistimulerende faktoraktivitetspromotorer

Country Status (12)

Country Link
EP (1) EP0409040B1 (pt)
JP (1) JPH04501860A (pt)
AT (1) ATE129158T1 (pt)
AU (1) AU638473B2 (pt)
CA (1) CA2035861A1 (pt)
DE (1) DE69023060T2 (pt)
DK (1) DK0409040T3 (pt)
ES (1) ES2088925T3 (pt)
GR (1) GR3018675T3 (pt)
IE (1) IE72139B1 (pt)
PT (1) PT94641A (pt)
WO (1) WO1991000919A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145676A (en) * 1981-09-08 1992-09-08 The Rockefeller University Method and agents for promoting wound healing
US5154921A (en) * 1990-07-13 1992-10-13 Dana-Farber Cancer Institute, Inc. Promotion of maturation of hematopoietic progenitor cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1208546A (en) * 1981-09-08 1986-07-29 Anthony Cerami Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
JP3022566B2 (ja) * 1987-10-02 2000-03-21 ザ ロックフェラー ユニバーシティ 大食細胞誘導炎症性神経細胞
WO1990002762A1 (en) * 1988-09-02 1990-03-22 The Rockefeller University Macrophage-derived inflammatory mediator (mip-2)

Also Published As

Publication number Publication date
AU6040290A (en) 1991-02-06
WO1991000919A1 (en) 1991-01-24
ES2088925T3 (es) 1996-10-01
CA2035861A1 (en) 1991-01-11
EP0409040B1 (en) 1995-10-18
ATE129158T1 (de) 1995-11-15
EP0409040A1 (en) 1991-01-23
IE72139B1 (en) 1997-03-26
JPH04501860A (ja) 1992-04-02
PT94641A (pt) 1991-04-18
DE69023060T2 (de) 1996-04-18
AU638473B2 (en) 1993-07-01
GR3018675T3 (en) 1996-04-30
DE69023060D1 (de) 1995-11-23

Similar Documents

Publication Publication Date Title
ATE201827T1 (de) Methoden und mittel zur förderung der wundheilung
NL990033I2 (nl) Tumornecrosefactor, werkwijzen om het te bereiden,samenstellingen die het bevatten, DNA dat ervoor codeert en proefmethoden met degelijk DNA.
ES2083469T3 (es) Peptido asociado a una latencia y utilizaciones del mismo.
GR3036686T3 (en) Therapeutic uses of bactericidal/permeability increasing protein products
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
ATE364614T1 (de) Tumornekrose-faktor-gamma
CA2006473A1 (en) Improved anti-infective therapy
IT1212892B (it) Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
SE8804036L (sv) Ny anvaendning av 11,28-dioxa-4-azatricklo (22.3.1.04.9)-oktakos-18-en-derivat och farmaceutiska kompositioner innehaallande desamma
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
ATE232396T1 (de) Oxydiertes thymosin beta 4
HUP9903921A2 (hu) Tumor nekrózis faktorral rokon ligandum
FR2525604B2 (fr) Acides aza bicyclo heptane carboxyliques substitues, leur preparation et leur application en therapeutique
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
ATE71662T1 (de) Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
DK0409040T3 (da) Kolonistimulerende faktoraktivitetspromotorer
JPH02500643A (ja) 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法
ES2058282T3 (es) Derivados de fenol, su produccion y uso.
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
Christophers et al. Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP
FR2568879B1 (fr) Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique
FR2549835B1 (fr) Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens